Immunotherapies move beyond cancer, with first foray into sepsis
(By Asher Mullard for STAT) Drug developers have tried for decades without success to develop treatments for sepsis, a brutal infection
Read More(By Asher Mullard for STAT) Drug developers have tried for decades without success to develop treatments for sepsis, a brutal infection
Read MoreOn Tuesday, America’s Health Insurance Plans or AHIP, the main lobby for the industry released a position paper listing the
Read MoreIn Kiplinger’s Ask Kim column, Kimberly Lankford answers the reader’s question on whether or not they need Medicare Part D
Read More(By Anna Gorman for Kaiser Health News) CONCORD, Calif. — Mary De Freze, who has heart problems, chronic lung disease
Read More(By Brian Zimmerman for Becker’s Hospital Review) A dentist working at the Tomah (Wis.) Veterans Affairs Medical Center put nearly
Read MorePresident-elect Donald Trump has repeatedly said he wanted to protect Medicare not overhaul it and that message has been reiterated
Read More(By Jay Hancock for Kaiser Health News) Penny Gentieu did not intend to phone 308 physicians in six different insurance
Read More(By Carmen Heredia Rodriguez for Kaiser Health News) Baby boomers are getting high in increasing numbers, reflecting growing acceptance of the
Read More(By Ed Silverman for STAT) Yet another major drug maker is pledging to limit price hikes. Continue reading article here…
Read MoreDecember 7th is the deadline to switch from traditional Medicare to a Medicare Advantage plan effective for January 2017. Read
Read More